Skip to main content

mHealth in India- What works and what not?


From remote monitoring to disease management, wireless technology is helping to improve healthcare outcomes and address the healthcare worker shortage. In the U.S., chronic disease treatment costs more than $1.4 trillion each year, but using mHealth could mean a savings of more than $21.1 billion per year.

But in India there is this unique pattern of adoption and push that is to be understood. Over the last decade, telehealth in India has been primarily facilitated and driven by government funding. The government now has a majorpolicy initiative in mobile health. However, in pursuing the broad initiative there is a danger that some of the smaller components can get lost, and this is probably what has happened to telehealth. Many government-driven telemedicine programmes have failed to live a long life. It is no secret that these programmes do not have a successful business model and die after the government grants run out. But if you are a medical device, mhealth app or Disease management software company based out of US or Europe eyeing India as a market-> Follow the money-> i.e. Government contracts.


As a mHealth Consultant, we tried several innovations in the country (already 67+ projects in my kitty) and here is the report card as far as stakeholders are concerned. No wonder, the maximum push is from the Government side but the things that are lacking is a concrete business model? So does that mean there is no for-profit model for mHealth in India.

The answer is YES, there is but we are still gearing up. I have met several companies from Switzerland, Israel, US and Europe and the whole reason for them to enter the Indian market was cashing on consumerism and scale. Remember, things may not turn out in your favour for the first 3 years if you are working on a for-profit model in India, so you have to be patient and try and work with the right partners and channels. However, quick money is always something that Government tenders provide.

As far as services are concerned Remote monitoring in India has not taken up as yet. Below given is a infograph on some of these services and their adoption in the country. Also refer to our survey report on Diabetes monitoring.

At this point in time, more than 4 large states in India are looking to set up a Non-emergency help line for consumers and people who live in rural areas and do not have access to basic health. Tele-triage companies from US and Europe have already submitted their interest for the same. Similarly, mobile clinics, telemedicine centres and health information on mobile phones is catching up as priorities amongst Indian Government. We all know about Dr SMS - an initiative of Kerala Government. (Healthcursor Consulting Group has prepared a report on several such reforms that were implemented by Govt. of India from the year 2005 onwards and lessons learnt - available for a price on the website).

There appear to be a number of steps required if telehealth in India is to keep up the pace of development, as we move into what is now being called the era of m-health, involving visual media, skype and hub and spoke based remote health service delivery. This area is changing extremely rapidly and is increasingly migrating away from the public sector in India, where most of the developmental work has occurred, and into the private sector. Some of the factors that lack in Govt. based implementations here are:

1. Patient satisfaction – do patients like the technology?

2. Clinical efficacy – how well we can treat the patients remotely rather than face to face?
3. Business case and sustainability – development of clear metrics to measure the project, including for example decreasing number of transports, reduced rate of hospitalisation and increased productivity. Many of the issues require consideration within the domain of m-health in India are also relevant to other countries. M-health will significantly change the way that health-care is practised in future, and it is clear that it is the human factors that are more difficult to overcome, rather than the technological ones.

Popular posts from this blog

Artificial Intelligence Policy and Governance in HEALTHCARE

  Artificial Intelligence has become the new frontier for digital transformation. Several  #digitalhealth  businesses of today rely on Machine Learning,  #AI  and other such technologies to make healthcare delivery more efficient and comprehensive. However, the efficient and responsible use of AI tools is an ongoing discussion and would mean culture, data management, technology shifts in the industry, and required up-grading and training professionals for better coordination. Hence, with the growing market potential and interest in AI, it is imperative to develop a thoughtthrough regulatory and legal framework on the adoption and use of AI. I have set forward a hypotheses to design a policy framework for AI technologies in my paper- "𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐨𝐥𝐢𝐜𝐲 – 𝐀 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞" last year https://lnkd.in/emi3XWwa cited further by "𝐓𝐡𝐞 𝐐𝐮𝐚𝐧𝐝𝐚𝐫𝐲 𝐢𝐧 𝐃𝐚𝐭𝐚 𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐑

Artificial intelligence and Technology for Dentistry

Have you heard of this company  ORCA Dental AI ? ORCA combines clinical expertise with machine learning and AI technologies to create diagnostic reports, treatment plan suggestions and smart clinical predictions. Good to learn about these innovations that benefit every stakeholder in the value chain. Recently,  VideaHealth  raised $20M to Expand AI-Based Diagnostics led by Spark Capital including existing investors Zetta Venture Partners. Among its many benefits to dentists and patients are: – A 31% increase in diagnosis rate for cavities and 26% increase in treatment plan value; – An increase in case acceptance by patients due to second opinions; – Automated workflows accelerate treatment planning and charting; Another company touting AI-powered dental care and practice management is  Overjet , which announced a $42.5 million Series B funding round in December months after it had scored $27 million in Series A funding.  Pearl  provides AI for dental images to assist in diagnosis. It l

Big Data Analytics- The Microscope and Telescope for Pharma/CRO

This article is produced in consultation with Industry experts, and KOLs in India and across the world and especially highlights how “Predictive Analytics algorithms” are poised to provide Useful Analytics to the Pharma industry.   In today’s highly competitive market, it is extremely important for contract research and manufacturers to have access to information that allows them to target the specific segments of the pharmaceutical and biotechnology industry that are looking to outsource the particular services they provide.  Understanding shifts in annual outsourcing budgets and spending can help CROs and CMOs to better position themselves for capturing business, particularly at a time when many – if not all – pharma and biotech companies are looking to cut costs and streamline operations.  As per a recent report by NiceInsights, Analytical Services, Clinical Research, and Clinical Monitoring will be the most demanded services over the next 12 to 18 months. For CROs and CMOs looki